RxDoctor Payments Data

Felipe Samaniego

Medical Oncology · Houston, TXNPI 1871675249

Payments from drug & device makers

$2,145,565in general payments, 2019–2025

Across 124 payments — averaging $17,303 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka Pharmaceutical Co., Ltd.$1.1M
  • Acerta Pharma LLC$344K
  • Bristol Myers Squibb$183K
  • TG Therapeutics, Inc.$125K
  • Janssen Research & Development, LLC$118K
  • Takeda Pharmaceuticals U.S.A., Inc.$87K
  • plus $142K from 9 others
$16in research payments, 2019–2025

Across 1 payment — averaging $15.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • TG Therapeutics, Inc.$16

What the payments were for

  • Consulting fees$7,05598%
  • Food & beverage$1021%
  • Education$551%

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,145,565 in reported general payments places this provider in the 80th percentile of 495 medical oncology providers in Texas.

See all medical oncology providers in Texas

Other medical oncology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →